Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
We describe the emergence of resistance to ceftazidime/avibactam via modification of AmpC in a clinical isolate during therapy with this combination. Paired ceftazidime/avibactam-susceptible/resistant isolates were obtained before and during ceftazidime/avibactam treatment. Whole genome sequencing revealed a differential mutation in AmpC (R148W) in the ceftazidime/avibactam-resistant isolate. Molecular cloning and structural studies confirmed the impact of this substitution, which affects the architecture of the H10 helix, on the evolved resistant phenotype.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11619368 | PMC |
| http://dx.doi.org/10.1128/aac.01307-24 | DOI Listing |
Publication Analysis
Top Keywords
emergence resistance
8
resistance ceftazidime/avibactam
8
ceftazidime/avibactam modification
8
modification chromosomal
4
chromosomal ampc
4
ampc β-lactamase
4
β-lactamase describe
4
describe emergence
4
modification ampc
4
ampc clinical
4